Diao et al. also identified NKT cell-derived OPN as a novel target for treating inflammatory liver diseases via augmenting NKT cell activation and triggering neutrophil infiltration and activation (Diao et al., 2004). The gene discussed is SPP1; the disease is liver disorder.